MARKET

BMY

BMY

Bristol-Myers Squibb Co
NYSE
67.01
+1.54
+2.35%
After Hours: 67.00 -0.01 -0.01% 19:59 08/21 EDT
OPEN
65.79
PREV CLOSE
65.47
HIGH
67.55
LOW
65.13
VOLUME
6.84M
TURNOVER
--
52 WEEK HIGH
68.64
52 WEEK LOW
41.13
MARKET CAP
136.88B
P/E (TTM)
14.76
1D
5D
1M
3M
1Y
5Y
1D
SA Asks: What are the most promising oncology companies right now?
Seeking Alpha · 4h ago
Buy 4 Barron's Better Bets (Than T-Bills) Out Of 11 'Safer' August DiviDogs
Seeking Alpha · 9h ago
Bristol-Myers Squibb Adds Early Alzheimer’s Antibody To Its Long-Term Growth Story
TipRanks · 1d ago
Lawmakers ask FDA to scrutinize Chinese trials amid deaths - report
Seeking Alpha · 1d ago
Here's Why Bristol Myers Squibb (BMY) is a Strong Momentum Stock
NASDAQ · 1d ago
Analysts Offer Insights on Healthcare Companies: Bristol-Myers Squibb (BMY), Revolution Medicines (RVMD) and MDxHealth (MDXH)
TipRanks · 1d ago
Bristol Myers Squibb (BMY) Teams Up On AI Antibody Discovery Push
Simply Wall St · 1d ago
Bristol‑Myers Squibb Advances Navlimetostat Metabolism Study, Signaling Steady Pipeline Progress
TipRanks · 2d ago
More
About BMY
Bristol-Myers Squibb Company is a global biopharmaceutical company. It is engaged in the discovery, development, and delivery of transformational medicines for patients facing serious diseases in areas: oncology, hematology, immunology, cardiovascular, neuroscience and other areas. Its growth portfolio includes Opdivo (nivolumab), Opdivo Qvantig (nivolumab and hyaluronidase-nvhy), Orencia (abatacept), Yervoy (ipilimumab), Reblozyl (luspatercept-aamt), Breyanzi (lisocabtagene maraleucel), Opdualag (nivolumab and relatlimab-rmbw), Camzyos (mavacamten), Zeposia (ozanimod), Abecma (idecabtagene vicleucel), Sotyktu (deucravacitinib), Krazati (adagrasib), and Cobenfy (xanomeline and trospium chloride). Its other growth products include Augtyro, Onureg, Inrebic, Nulojix, and Empliciti. Its legacy portfolio includes Eliquis (apixaban), Revlimid (lenalidomide), Pomalyst/Imnovid (pomalidomide), Sprycel (dasatinib), and Abraxane (paclitaxel albumin-bound particles for injectable suspension).

Webull offers Bristol-Myers Squibb Co stock information, including NYSE: BMY real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, BMY stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading BMY stock methods without spending real money on the virtual paper trading platform.